Skip to main content

Guided Therapeutics, Inc. (GTHP)

OTCMKTS: GTHP · Delayed Price · USD
0.630 -0.010 (-1.56%)
Nov 19, 2021 4:00 PM EST - Market closed
Market Cap8.38M
Revenue (ttm)104,000
Net Income (ttm)2.19M
Shares Out13.30M
EPS (ttm)0.02
PE Ratio42.00
Forward PEn/a
Ex-Dividend Daten/a
Previous Close0.640
Day's Range0.590 - 0.640
52-Week Range0.085 - 1.000
Price Targetn/a
Earnings Daten/a

About GTHP

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 199...

IndustryMedical Devices
IPO DateJul 1, 1997
CEOMark Faupel
Stock ExchangeOTCMKTS
Ticker SymbolGTHP
Full Company Profile


There is no news available yet.